Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

V. Roy, A. K. Stewart, P. L. Bergsagel, A. Dispenzieri, K. Laumann, J. Allred, M. Q. Lacy, R. Fonseca, C. B. Reeder, S. Kumar, C. E. Rivera, M. A. Gertz, F. K. Buadi, S. R. Hayman, S. V. Rajkumar

Research output: Contribution to journalLetter

4 Scopus citations
Original languageEnglish (US)
Article numbere294
JournalBlood cancer journal
Volume5
Issue number3
DOIs
StatePublished - Mar 20 2015

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this